OR-1896
OR-1896 is an active long-lived metabolite of Levosimendan. OR-1896 is a highly selective phosphodiesterase (PDE) III isoform inhibitor and a powerful vasodilator. OR-1896 can open ATP-sensitive K+ channels and has Ca2+-sensitizing effect. OR-1896 mitigates cardiomyocyte apoptosis, cardiac remodeling and myocardial inflammation[1].
Product Specifications
CAS Number
220246-81-1
UNSPSC
12352005
Target
Apoptosis; Drug Metabolite; Phosphodiesterase (PDE) ; Potassium Channel
Type
Reference compound
Related Pathways
Apoptosis; Membrane Transporter/Ion Channel; Metabolic Enzyme/Protease
Applications
COVID-19-immunoregulation
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/or-1896.html
Purity
99.04
Solubility
DMSO : 62.5 mg/mL (ultrasonic)
Smiles
CC(NC1=CC=C(C([C@H](C)C2)=NNC2=O)C=C1)=O
Molecular Formula
C13H15N3O2
Molecular Weight
245.28
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
PDE3
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Lentiviral human ABCA12 shRNA (UAS) - Lentiviral human ABCA12 shRNA (UAS, iRFP) (25)
Biotin Linked Monoclonal Antibody to Cluster Of Differentiation 8b (CD8b)
Biotin Linked Monoclonal Antibody to Cluster Of Differentiation 8b (CD8b)
Biotin Linked Monoclonal Antibody to Cluster Of Differentiation 8b (CD8b)
Biotin Linked Monoclonal Antibody to Cluster Of Differentiation 8b (CD8b)